Form 4 for IMRX Immuneering Corp
Accepted 2026-01-15 00:00:00 ET · period of report 2026-01-13 · accession 0001790340-26-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-15 | 2026-01-13 | IMRX | Neufeld Leah R | CHRO | P - Purchase | $4.15 | +2,626 | 26.0K | +11% | +$10.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2026-01-13 | P | A | 2,626 | $4.15 | 25,970 | D | — | — |